Ed Hyman, chairman of Evercore ISI, just pivoted to a soft landing from a hard one. Hyman is one of the most closely watched economists on Wall Street, known for his domination of the ...
CRISPR Therapeutics shares jump after Evercore ISI upgraded the stock to Outperform from In Line.Julie Hyman and Josh Schafer examine what the analysts say about the biotech company on Market ...